Synthetic triple-incretin peptide · GLP-1 / GIP / glucagon receptor ligand · Studied in metabolic research.
$299.95
| Title | Range | Discount |
|---|---|---|
| Buy 3+ Save 5% | 3 - 4 | 5% |
| Buy 5+ Save 10% | 5 - 9 | 10% |
| Buy 10+ Save 20% | 10 + | 20% |
In stock
All products are supported by third-party laboratory testing and documented Certificates of Analysis. These reports confirm compound identity and purity, giving you direct access to the same data we use for quality verification.
Where a peptide CoA is still being finalised, the product is supplied while its documentation is in progress.
What is RET-GLP3?
RET-GLP3 (R3TA) is a synthetic single-chain peptide engineered to interact with three incretin-family receptors — GLP-1, GIP, and glucagon — within a single molecular scaffold. It is studied in laboratory research contexts related to metabolic biology, energy-balance signalling, and incretin-receptor pharmacology.
Product Specifications
Storage & Handling
Store below 8°C in a cool, dry environment, protected from light and moisture. Reconstitution with an appropriate sterile solvent is required prior to laboratory use, in accordance with standard research protocols.
Research Supplies
Bacteriostatic Water is required for reconstitution and is not included with this product. Bacteriostatic Water, syringes, and alcohol wipes are available separately under Research Supplies.
Research Use Only
This product is intended exclusively for professional scientific and laboratory applications. It is not for human or veterinary use, is not a medicine, and is not a dietary or nutritional supplement. No statement on this page describes or implies any therapeutic effect, and this product has not been evaluated by the Therapeutic Goods Administration or any comparable regulatory authority.
